[1]
Omar Sajjad et al. 2023. META-ANALYSIS OF THE PREVALENCE OF RENAL IMPAIRMENT IN PATIENTS WITH TESTICULAR CANCER RECEIVING *CISPLATIN-BASED CHEMOTHERAPY. Journal of Population Therapeutics and Clinical Pharmacology. 30, 19 (Dec. 2023), 2462–2466. DOI:https://doi.org/10.53555/wmgdh233.